Patient Information

Dear Patient,

Your physician has chosen a Medical Device manufactured by Regenlab to be used during your planned treatment. Your physician will discuss the planned treatment plan, the mode of action and future risks and possible therapy options with you in detail in a private interview prior to the procedure.

This information should not replace the private discussion with your physician.

Please refer to your Medical Device name below :

  • Cellular Matrix A-CP-HA, Ref.: A-CP-HA-1, A-CP-HA-3
  • Cellular Matrix BCT-HA, Ref.: BCT-HA-1, BCT-HA-3

Our products are compliant with the Medical Device Regulation EU 2017/745. For Cellular Matrix products, patient information leaflets are available. You can download the specific leaflet you need for each product below.

Patient Information Leaflet

Click on your language and access the dedicated leaflet

Patient Information Leaflet
| български език
Patient Information Leaflet
| Česky
Patient Information Leaflet
| Deutsch
Patient Information Leaflet
| Ελληνικά
Patient Information Leaflet
| Español
Patient Information Leaflet
| Eesti keel
Patient Information Leaflet
| Suomen kieli
Patient Information Leaflet
| Français
Patient Information Leaflet
| Hrvatski
Patient Information Leaflet
| Italiano
Patient Information Leaflet
| Lietuvių kalba
Patient Information Leaflet
| Latviešu valoda
Patient Information Leaflet
| Nederlands
Patient Information Leaflet
| Norsk
Patient Information Leaflet
| Polski
Patient Information Leaflet
| Português
Patient Information Leaflet
| Română
Patient Information Leaflet
| Slovenčina
Patient Information Leaflet
| Slovenščina
Patient Information Leaflet
| Svenska
Patient Information Leaflet
| Türkçe
Cellular Matrix A-CP-HA | български език
Cellular Matrix A-CP-HA | Ελληνικά
Cellular Matrix A-CP-HA | Eesti keel
Cellular Matrix A-CP-HA | Suomen kieli
Cellular Matrix A-CP-HA | Lietuvių kalba
Cellular Matrix A-CP-HA | Latviešu valoda
Cellular Matrix A-CP-HA | Nederlands
Cellular Matrix A-CP-HA | Português
Cellular Matrix A-CP-HA | Slovenčina
Cellular Matrix A-CP-HA | Slovenščina

Patient Information Leaflet

An implant card will be supplied with the mentioned above products and is intended to be filled with your information by your physician after the medical procedure. You shall keep it for the time indicated in your leaflet.

About Us

Since 2003, Regen Lab SA has specialized in designing and manufacturing high-quality medical devices for cell therapies and the preparation of autologous platelet-rich plasma (PRP) from the patient's own blood for bedside procedures.

Milestones

2003 - Foundation
2010 - RegenKit first approval in bone graft
2013 - A new state-of-theart laboratory in Lausanne
2014 - Cellular Matrix first approval
2015 - Launch of Cellular Matrix in Europe

Vision

Founded in 2003, Regen Lab has become a global reference thanks to its commitment to innovation, quality, and the effectiveness of its therapeutic solutions. Here’s how we have transformed the medical landscape over the past two decades.

RegenPRP™

RegenPRP™ is a medical treatment that uses platelet-rich plasma from the patient's own blood to enhance and tissue regeneration.

RegenPRP™ - HA

RegenPRP™ - HA combination is an innovative treatment combining platelet-rich plasma (PRP) and hyaluronic acid to improve tissue regeneration and healing.

RegenPRP™ - ATS

RegenPRP™ combined with ATS (Autologous Thrombin Serum) is an advanced approach to tissue regeneration that uses autologous thrombin-enriched platelet-rich plasma (PRP) to maximise healing effects.

RegenExtracell®

RegenExtracell is an innovative tissue regeneration treatment using an extracellular matrix enriched with platelet-rich plasma (PRP).

Hyaluronic Acid

Coming Soon

Regulatory

Manufacturers of medical devices based outside the EU must designate an Authorized Representative (EC-REP) established within the EU in order to meet the CE requirements for placing medical devices on the EU market.

Quality Management

Regen Lab Quality System Management ensures the consistency of our products quality in total GMP compliance.

Our production facility rooms atmosphere is monitored to satisfy non-pyrogenic medical devices manufacturing.

Patents

As a leader in the PRP&HA regenerative field and as an innovation-driven company, Regen Lab SA has devoted important resources since 2004 to put on the market pioneering and diversified products constituting a complete set of tools/technologies for the medical community.